RxSight, Inc.
Index- P/E- EPS (ttm)-2.40 Insider Own0.80% Shs Outstand27.43M Perf Week2.32%
Market Cap359.44M Forward P/E- EPS next Y-2.21 Insider Trans0.00% Shs Float21.53M Perf Month0.57%
Income-59.50M PEG- EPS next Q-0.71 Inst Own39.20% Short Float2.74% Perf Quarter3.68%
Sales28.10M P/S12.79 EPS this Y22.10% Inst Trans26.73% Short Ratio5.99 Perf Half Y25.24%
Book/sh4.49 P/B3.14 EPS next Y20.50% ROA-35.60% Target Price21.00 Perf Year-
Cash/sh5.64 P/C2.50 EPS next 5Y- ROE-240.60% 52W Range8.80 - 19.67 Perf YTD25.24%
Dividend- P/FCF- EPS past 5Y- ROI-29.70% 52W High-28.37% Beta-
Dividend %- Quick Ratio14.30 Sales past 5Y- Gross Margin25.50% 52W Low60.11% ATR1.21
Employees87 Current Ratio15.10 Sales Q/Q154.30% Oper. Margin- RSI (14)50.68 Volatility7.54% 9.47%
OptionableNo Debt/Eq0.33 EPS Q/Q-147.90% Profit Margin- Rel Volume1.36 Prev Close15.18
ShortableYes LT Debt/Eq0.32 EarningsMay 05 AMC Payout- Avg Volume98.49K Price14.09
Recom1.60 SMA20-2.98% SMA506.00% SMA20013.21% Volume131,597 Change-7.18%
Apr-08-22Initiated Needham Buy $18
May-08-22 08:21AM  
May-06-22 11:00AM  
May-05-22 04:05PM  
May-04-22 03:51PM  
Apr-22-22 09:00AM  
Apr-21-22 04:05PM  
Apr-19-22 04:30PM  
Mar-28-22 04:05PM  
Mar-08-22 09:30PM  
Mar-04-22 06:38AM  
Mar-01-22 08:00AM  
Feb-23-22 04:10PM  
Feb-03-22 04:05PM  
Jan-09-22 04:00PM  
Jan-04-22 04:05PM  
Dec-28-21 04:05PM  
Nov-18-21 04:05PM  
Nov-11-21 11:30AM  
Nov-10-21 04:05PM  
Nov-02-21 03:41PM  
Oct-27-21 04:05PM  
Sep-09-21 04:05PM  
Sep-01-21 08:00AM  
Aug-31-21 08:00AM  
Aug-24-21 04:05PM  
Aug-17-21 04:05PM  
Aug-10-21 08:05PM  
Aug-04-21 04:05PM  
Jul-29-21 10:17PM  
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Corley Jesse AndersonDirectorNov 17Buy12.488,150101,75314,009Nov 18 05:02 PM